Eva Honsova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eva Honsova has a total of 360 co-authors. Here are the top co-authors by number of shared publications:
- Martin Oliverius
Department of Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
9 shared publications - Ondrej Viklicky
Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
7 shared publications - Janka Slatinska
Institute for Experimental and Clinical Medicine, Prague, Czech Republic
5 shared publications - Pavel Trunecka
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
4 shared publications Alena Lodererova
3 shared publications- Beatrice Mohelnikova-Duchonova
Department of Oncology and Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
3 shared publications
Latest Publications
- Open Access
- 11 October 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1654
New Imaging Markers of Clinical Outcome in Asymptomatic Patients with Severe Aortic Regurgitation
Background: Determining the value of new imaging markers to predict aortic valve (AV) surgery in asymptomatic patients with severe aortic regurgitation (AR) in a prospective, observational, multicenter study. Methods: Consecutive patients with chronic severe AR were enrolled between 2015–2018. Baseline examination included echocardiography (ECHO) with 2- and 3-dimensional (2D and 3D) vena contracta area (VCA), and magnetic resonance imaging (MRI) with regurgitant volume (RV) and fraction (RF) analyzed in CoreLab. Results: The mean follow-up was 587 days (interquartile range (IQR) 296–901) in a total of 104 patients. Twenty patients underwent AV surgery. Baseline clinical and laboratory data did not differ between surgically and medically treated patients. Surgically treated patients had larger left ventricular (LV) dimension, end-diastolic volume (all p < 0.05), and the LV ejection fraction was similar. The surgical group showed higher prevalence of severe AR (70% vs. 40%, p = 0.02). Out of all imaging markers 3D VCA, MRI-derived RV and RF were identified as the strongest independent predictors of AV surgery (all p < 0.001). Conclusions: Parameters related to LV morphology and function showed moderate accuracy to identify patients in need of early AV surgery at the early stage of the disease. 3D ECHO-derived VCA and MRI-derived RV and RF showed high accuracy and excellent sensitivity to identify patients in need of early surgery.
- 11 October 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1654
Open AccessNew Imaging Markers of Clinical Outcome in Asymptomatic Patients with Severe Aortic Regurgitation
Background: Determining the value of new imaging markers to predict aortic valve (AV) surgery in asymptomatic patients with severe aortic regurgitation (AR) in a prospective, observational, multicenter study. Methods: Consecutive patients with chronic severe AR were enrolled between 2015–2018. Baseline examination included echocardiography (ECHO) with 2- and 3-dimensional (2D and 3D) vena contracta area (VCA), and magnetic resonance imaging (MRI) with regurgitant volume (RV) and fraction (RF) analyzed in CoreLab. Results: The mean follow-up was 587 days (interquartile range (IQR) 296–901) in a total of 104 patients. Twenty patients underwent AV surgery. Baseline clinical and laboratory data did not differ between surgically and medically treated patients. Surgically treated patients had larger left ventricular (LV) dimension, end-diastolic volume (all p < 0.05), and the LV ejection fraction was similar. The surgical group showed higher prevalence of severe AR (70% vs. 40%, p = 0.02). Out of all imaging markers 3D VCA, MRI-derived RV and RF were identified as the strongest independent predictors of AV surgery (all p < 0.001). Conclusions: Parameters related to LV morphology and function showed moderate accuracy to identify patients in need of early AV surgery at the early stage of the disease. 3D ECHO-derived VCA and MRI-derived RV and RF showed high accuracy and excellent sensitivity to identify patients in need of early surgery.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i280-i281
FP696ISOLATED V-LESION EARLY AFTER KIDNEY TRANSPLANTATION MAY NOT TRULY REPRESENT A REJECTION
INTRODUCTION AND AIMS: Acute vascular rejection (AVR) is known to be a negative prognostic factor for kidney allograft survival. However, a role of early isolated v-lesion (IV) defined as intimal arteritis with minimal tubulointerstitial inflammation (TI) is unclear. While some authors believe in hidden ischemic/reperfusion injury, others are convinced of its rejection origin. To help resolve if IV truly represents acute rejection, molecular profiling of IV and T-cell mediated vascular rejection (TCMRV) was performed.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i280-i281
FP696ISOLATED V-LESION EARLY AFTER KIDNEY TRANSPLANTATION MAY NOT TRULY REPRESENT A REJECTION
INTRODUCTION AND AIMS: Acute vascular rejection (AVR) is known to be a negative prognostic factor for kidney allograft survival. However, a role of early isolated v-lesion (IV) defined as intimal arteritis with minimal tubulointerstitial inflammation (TI) is unclear. While some authors believe in hidden ischemic/reperfusion injury, others are convinced of its rejection origin. To help resolve if IV truly represents acute rejection, molecular profiling of IV and T-cell mediated vascular rejection (TCMRV) was performed.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i596-i597
SP737DO C1Q-POSITIVE DONOR SPECIFIC ANTIBODIES HAVE PROGNOSTIC EFFECT IN PATIENTS WITH RESISTANT ANTIBODY-MEDIATED REJECTION TREATED WITH BORTEZOMIB? SINGLE- CENTRE EXPERIENCE
INTRODUCTION AND AIMS: Donor-specific antibodies (DSAs) examination is a crucial part of antibody-mediated rejection (AMR) diagnosis. C1q-positive (+) DSAs are associated with poor graft survival. We analyzed results of patients treated for resistant AMR by a bortezomib-based regimen with retrospectively performed C1q assay. The aim of this work was to analyze the treatment effect on DSA levels and potential effect of C1q+ DSAs on graft survival.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i596-i597
SP737DO C1Q-POSITIVE DONOR SPECIFIC ANTIBODIES HAVE PROGNOSTIC EFFECT IN PATIENTS WITH RESISTANT ANTIBODY-MEDIATED REJECTION TREATED WITH BORTEZOMIB? SINGLE- CENTRE EXPERIENCE
INTRODUCTION AND AIMS: Donor-specific antibodies (DSAs) examination is a crucial part of antibody-mediated rejection (AMR) diagnosis. C1q-positive (+) DSAs are associated with poor graft survival. We analyzed results of patients treated for resistant AMR by a bortezomib-based regimen with retrospectively performed C1q assay. The aim of this work was to analyze the treatment effect on DSA levels and potential effect of C1q+ DSAs on graft survival.
- 1 June 2017
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101 (6S2) , S138
Short Term Results of Intestinal Transplantation in Czech Republic
- 1 June 2017
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101 (6S2) , S138
Short Term Results of Intestinal Transplantation in Czech Republic
- 1 June 2017
- Published by Elsevier in Transplant Immunology
- Vol. 42, 18-23
Steroid free immunosuppression is associated with enhanced Th1 transcripts in kidney transplantation
- 1 June 2017
- Published by Elsevier in Transplant Immunology
- Vol. 42, 18-23
Steroid free immunosuppression is associated with enhanced Th1 transcripts in kidney transplantation
- 1 October 2015
- Published by Elsevier in Transplant Immunology
- Vol. 33 (2) , 63-68
Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft
- 1 October 2015
- Published by Elsevier in Transplant Immunology
- Vol. 33 (2) , 63-68
Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft
- 17 September 2015
- Vol. 61, 725-30
[AB0 incompatible kidney transplantation - first experiences].
Living donor AB0 incompatible kidney transplantation represents a new tool how to improve the access to transplantation. Majority of European protocols are based on desensitization with rituximab, triple drug immunosuppression, intravenous immunoglobulins and specific immunoads option (IA) which eliminates isohaemaglutinins. AB0i kidney transplant program was initiated in our centre in 2011 and 21 patients have received grafts from incompatible donors until recently. Highest accepted isohaemaglutinins titers before rituximab were 1 : 64 and corresponding pretransplant immunoadsorption procedures varied from 2 to 9. In 5 patients 1-2 IA procedures were performed also after transplantation. With the advent of paired exchange program the AB0i transplantation is offered to patients with unsuccessful matching run or with aim to improve HLA match between donor and recipient. The main complications were postoperative bleeding and urinary tract infections in patients at risk. Majority of protocol biopsies exhibited positivity of C4d staining. Neither graft loss nor patient death were noticed.
- 17 September 2015
- Vol. 61, 725-30
[AB0 incompatible kidney transplantation - first experiences].
Living donor AB0 incompatible kidney transplantation represents a new tool how to improve the access to transplantation. Majority of European protocols are based on desensitization with rituximab, triple drug immunosuppression, intravenous immunoglobulins and specific immunoads option (IA) which eliminates isohaemaglutinins. AB0i kidney transplant program was initiated in our centre in 2011 and 21 patients have received grafts from incompatible donors until recently. Highest accepted isohaemaglutinins titers before rituximab were 1 : 64 and corresponding pretransplant immunoadsorption procedures varied from 2 to 9. In 5 patients 1-2 IA procedures were performed also after transplantation. With the advent of paired exchange program the AB0i transplantation is offered to patients with unsuccessful matching run or with aim to improve HLA match between donor and recipient. The main complications were postoperative bleeding and urinary tract infections in patients at risk. Majority of protocol biopsies exhibited positivity of C4d staining. Neither graft loss nor patient death were noticed.
- 1 June 2015
- Published by Elsevier in Pancreatology
- Vol. 15 (3) , S37
Importance of hedgehog signaling pathway in pancreatic cancer treatment and prognosis
- 1 June 2015
- Published by Elsevier in Pancreatology
- Vol. 15 (3) , S37
Importance of hedgehog signaling pathway in pancreatic cancer treatment and prognosis
- 1 January 2015
- Vol. 51 (4) , 166-8
[Diagnosis of rejection in a transplanted liver].
Despite advances in immunosupressive therapy rejection remains the most common complication of liver transplantation in both the early and the late post-transplant period. Unlike other solid organs, liver graft rejection has some specific characteristics likely attributable to the unique immunobiologic properties and the remarkable regenerative capabilities of liver parenchyma. Acute cellular rejection is the most frequent type of the rejection episode in the liver allograft, whereas chronic (ductopenic) rejection and humoral rejection are uncommon. Since the clinical findings are not entirely characteristic, histopathological evaluation of liver biopsy remains the gold standard in the diagnosis of rejection. However, the close cooperation between the pathologist and the clinician is essential for the correct interpretation of morphologic changes.
- 1 January 2015
- Vol. 51 (4) , 166-8
[Diagnosis of rejection in a transplanted liver].
Despite advances in immunosupressive therapy rejection remains the most common complication of liver transplantation in both the early and the late post-transplant period. Unlike other solid organs, liver graft rejection has some specific characteristics likely attributable to the unique immunobiologic properties and the remarkable regenerative capabilities of liver parenchyma. Acute cellular rejection is the most frequent type of the rejection episode in the liver allograft, whereas chronic (ductopenic) rejection and humoral rejection are uncommon. Since the clinical findings are not entirely characteristic, histopathological evaluation of liver biopsy remains the gold standard in the diagnosis of rejection. However, the close cooperation between the pathologist and the clinician is essential for the correct interpretation of morphologic changes.